ibuprofén zentiva k.s. 400 mg
zentiva k.s., Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica
ibuprofén zentiva 400 mg
zentiva k.s., Česká republika - ibuprofén - 07 - analgetica, antipyretica
ibuprofén zentiva 200 mg
zentiva k.s., Česká republika - ibuprofén - 07 - analgetica, antipyretica
stribu 400 mg filmom obalené tablety
strides pharma (cyprus) limited, cyprus - ibuprofén - 07 - analgetica, antipyretica
stribu 200 mg filmom obalené tablety
strides pharma (cyprus) limited, cyprus - ibuprofén - 07 - analgetica, antipyretica
combogesic 32 mg/ml + 9,6 mg/ml perorálna suspenzia
medochemie ltd., cyprus - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hydrochlorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidlá - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
ketonal forte 100 mg
sandoz pharmaceuticals d.d., slovinsko - ketoprofén - 29 - antirheumatica, antiphlogistica, antiuratica
avaglim
smithkline beecham ltd - rosiglitazone, glimepiride - diabetes mellitus, typ 2 - lieky používané pri cukrovke - avaglim je indikovaný v liečbe diabetes mellitus 2. typu u pacientov, ktorí nie sú schopní dosiahnuť dostatočné glykemický kontroly na optimálne dávkovanie sulfonylmocoviny monotherapy, a pre ktorých je metformín je nevhodné z dôvodu kontraindikácie alebo neznášanlivosti.
anopyrin 100 mg
zentiva a.s., slovensko - kyselina acetylsalicylová - 16 - anticoagulantia (fibrinolytica, antifibrinol.)